- Dec 2019 Apr - Dec 2018 Change % Change Revenue from sales & service 634.48 791.59 -157.11 -19.9% 2,099.99 2,489.75 -389.76 -15.7% Other income 4.96 7.46 -2.50 -33.5% 14.89 20.29 -5.40 -26.6% Total
statement ended 30th Sept ended 30th Sept July - Sept 2020 July - Sept 2019 Change % Change Apr - Sept 2020 Apr - Sept 2019 Change % Change Revenue from sales & service 518.91 745.69 -226.78 -30.4% 930.49
- Sept 2019 Apr - Sept 2018 Change % Change Revenue from sales & service 745.69 844.39 -98.70 -11.7% 1,465.51 1,698.16 -232.65 -13.7% Other income 4.68 7.79 -3.11 -39.9% 9.94 12.82 -2.88 -22.5% Total
subsidiaries as details below: (Unit: Baht millions) For the year ended 31st March Consolidated financial statement Apr 2019 - Mar 2020 Apr 2018 - Mar 2019 Change % Change Revenue from sales & service 2,756.44
its subsidiaries as details below: (Unit: Baht millions) For the period of three months Consolidated financial statement ended 30th June Apr 2019 - June 2019 Apr 2018 - June 2018 Change % Change Revenue
2019 Change % Change Revenue from sales & service 411.58 719.81 -308.23 -42.8% Other income 5.01 5.57 -0.56 -10.1% Total revenue 416.59 725.38 -308.79 -42.6% Cost of goods sold & service 383.13 638.35
www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Type of Revenue 2019 2018 Change MB
%, increased from the same period last year by Baht 12.79 million or 16.7%, which changed in the same direction of revenue. The major change was due to increasing of branches rental expense, marketing and
-0.07 2.51 0.97 -0.90 -108.78 Change +/(-) Unit : million baht • The revenue of Q2/2019 is increased by 26.85 million baht comparing with Q1/2019 because higher revenue from both domestic market and
like to clarify a significance change of Group’s operation results were summarized as follows 1. Revenue from sales of goods and rendering of services for the year 2019 decreased by 13% compared to the